Changzhou Qianhong Biopharma Co Ltd Cash Flow Reinvestment Rate
Changzhou Qianhong Biopharma Co Ltd cash flow reinvestment rate. Changzhou Qianhong Biopharma Co Ltd (002550) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting CN¥15.58 Million (capex CN¥15.58 Million ) from operating cash flow of CN¥156.34 Million. Explore 002550 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Cash flow reinvestment rate of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. Historical reinvestment intensity for Changzhou Qianhong Biopharma Co Ltd across 18 annual periods. Explore capital reinvestment ratio of Changzhou Qianhong Biopharma Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Changzhou Qianhong Biopharma Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Changzhou Qianhong Biopharma Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Changzhou Qianhong Biopharma Co Ltd. For the full cash flow conversion analysis, see 002550 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | CN¥300.22 Million | CN¥361.36 Million | CN¥141.60 Million | ▲ +159.4% |
| 2024 | 0.32x | CN¥164.85 Million | CN¥514.71 Million | CN¥90.64 Million | ▼ -38.0% |
| 2023 | 0.52x | CN¥275.43 Million | CN¥533.33 Million | CN¥100.33 Million | ▼ -80.0% |
| 2021 | 2.58x | CN¥267.60 Million | CN¥103.56 Million | CN¥90.37 Million | ▲ +48.4% |
| 2020 | 1.74x | CN¥552.42 Million | CN¥317.28 Million | CN¥62.53 Million | ▼ -3.3% |
| 2019 | 1.80x | CN¥290.94 Million | CN¥161.55 Million | CN¥100.68 Million | ▼ -87.4% |
| 2018 | 14.28x | CN¥363.35 Million | CN¥25.45 Million | CN¥103.53 Million | ▲ +844.2% |
| 2017 | 1.51x | CN¥133.87 Million | CN¥88.52 Million | CN¥87.63 Million | ▲ +75.0% |
| 2016 | 0.86x | CN¥190.95 Million | CN¥221.01 Million | CN¥138.94 Million | ▼ -46.6% |
| 2015 | 1.62x | CN¥463.42 Million | CN¥286.50 Million | CN¥215.78 Million | ▲ +350.3% |
| 2014 | 0.36x | CN¥90.53 Million | CN¥252.01 Million | CN¥90.53 Million | ▼ -54.8% |
| 2013 | 0.80x | CN¥127.59 Million | CN¥160.47 Million | CN¥127.59 Million | ▲ +147.5% |
| 2012 | 0.32x | CN¥64.20 Million | CN¥199.82 Million | CN¥64.20 Million | ▲ +79.3% |
| 2011 | 0.18x | CN¥26.31 Million | CN¥146.82 Million | CN¥26.31 Million | ▲ +188.9% |
| 2010 | 0.06x | CN¥10.64 Million | CN¥171.51 Million | CN¥10.64 Million | ▼ -96.1% |
| 2009 | 1.60x | CN¥13.37 Million | CN¥8.35 Million | CN¥13.37 Million | ▲ +1075.1% |
| 2008 | 0.14x | CN¥7.41 Million | CN¥54.36 Million | CN¥7.41 Million | ▼ -29.6% |
| 2007 | 0.19x | CN¥6.97 Million | CN¥35.99 Million | CN¥6.97 Million | — |